IL72897A0 - Preparation for the transdermal application of active substances,and processes for the preparation thereof - Google Patents

Preparation for the transdermal application of active substances,and processes for the preparation thereof

Info

Publication number
IL72897A0
IL72897A0 IL72897A IL7289784A IL72897A0 IL 72897 A0 IL72897 A0 IL 72897A0 IL 72897 A IL72897 A IL 72897A IL 7289784 A IL7289784 A IL 7289784A IL 72897 A0 IL72897 A0 IL 72897A0
Authority
IL
Israel
Prior art keywords
preparation
processes
active substances
transdermal application
active medicinal
Prior art date
Application number
IL72897A
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL72897A0 publication Critical patent/IL72897A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/07—Microporous membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL72897A 1983-09-12 1984-09-10 Preparation for the transdermal application of active substances,and processes for the preparation thereof IL72897A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833333240 DE3333240A1 (de) 1983-09-12 1983-09-12 Mittel zur transdermalen applikation von arzneimittelwirkstoffen

Publications (1)

Publication Number Publication Date
IL72897A0 true IL72897A0 (en) 1984-12-31

Family

ID=6209098

Family Applications (1)

Application Number Title Priority Date Filing Date
IL72897A IL72897A0 (en) 1983-09-12 1984-09-10 Preparation for the transdermal application of active substances,and processes for the preparation thereof

Country Status (16)

Country Link
US (1) US5071657A (xx)
EP (1) EP0137278B1 (xx)
AT (1) ATE49126T1 (xx)
AU (1) AU3284984A (xx)
CA (1) CA1242143A (xx)
DE (2) DE3333240A1 (xx)
DK (1) DK164482C (xx)
ES (1) ES535860A0 (xx)
FI (1) FI83390C (xx)
GB (1) GB2146526B (xx)
GR (1) GR80327B (xx)
IL (1) IL72897A0 (xx)
NO (1) NO843594L (xx)
PH (1) PH21735A (xx)
PT (1) PT79182B (xx)
ZA (1) ZA847190B (xx)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8512016A8 (sl) * 1984-12-22 1996-10-31 Sanol Arznei Schwarz Gmbh Postopek za proizvodnjo obliža z aktivno substanco
ATE95430T1 (de) * 1984-12-22 1993-10-15 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster.
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
DE3600947A1 (de) * 1986-01-15 1987-07-16 Kali Chemie Pharma Gmbh Antimykotische emulsionen
US5560922A (en) * 1986-05-30 1996-10-01 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
FI872552A (fi) * 1986-06-09 1987-12-10 American Cyanamid Co Prostaglandinkomposition foer lokalt bruk.
FI872553A (fi) * 1986-06-09 1987-12-10 American Cyanamid Co Medium foer laekemedel foer lokalt bruk.
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
DE3710216A1 (de) * 1987-03-27 1988-10-06 Rentschler Arzneimittel Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
US4898920A (en) * 1987-10-15 1990-02-06 Dow Corning Corporation Adhesive compositions, controlled release compositions and transdermal delivery device
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
JP3238389B2 (ja) 1988-10-27 2001-12-10 シエーリング アクチエンゲゼルシヤフト ゲストデン含有の経皮適用のための薬剤
KR900701242A (ko) * 1988-12-01 1990-12-01 스타이너 브이. 캔스타드 에스트라디올의 경피전달용 조성물
JPH02258718A (ja) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
US5252335A (en) * 1989-07-12 1993-10-12 Cygnus Therapeutic Systems Transdermal administration of lisuride
US5229129A (en) * 1989-07-12 1993-07-20 Cygnus Therapeutic Systems Transdermal administration of lisuride
FR2650747B1 (fr) * 1989-08-11 1994-02-11 Oreal Film composite pour traitement cutane local et procedes de fabrication correspondants
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
DE4033524A1 (de) * 1990-10-22 1992-04-23 Sanol Arznei Schwarz Gmbh Pharmazeutische verwendung von 1-(tert-butylamino)-3-((6-chloro-m-tolyl)oxy)-2-propanol in einer transdermalen applikationsform
DE69126002T2 (de) * 1990-11-06 1997-08-28 Sagami Chem Res An einem Kettenende mit einem quaternären Salz abgeschlossenes Polyorganosiloxan und Mittel zur Förderung der perkutanen Absorption
DE4116912A1 (de) * 1991-05-18 1992-11-26 Schering Ag Mittel zur transdermalen applikation enthaltend ergolin-derivate
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
AU684483B2 (en) * 1992-11-23 1997-12-18 Estee Lauder Inc. Self-tanning cosmetic compositions and methods of using the same
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
ATE275957T1 (de) * 1993-01-19 2004-10-15 Endorech Inc Therapeutische verwendungen und verabreichungsysteme von dehydroepiandrosteron
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
US6086921A (en) 1995-04-25 2000-07-11 Wintrop-University Hospital Metal/thiol biocides
US6063398A (en) * 1995-09-20 2000-05-16 L'oreal Cosmetic or dermopharmaceutical patch containing, in an anhydrous polymeric matrix, at least one active compound which is, in particular, unstable in oxidizing mediums, and at least one water-absorbing agent
FR2738744B1 (fr) * 1995-09-20 1997-10-24 Oreal Patch cosmetique ou dermo-pharmaceutique contenant dans une matrice polymerique au moins un compose actif en particulier instable en milieu oxydant et au moins un agent hydro-absorbant
JP3406773B2 (ja) * 1996-03-26 2003-05-12 東レ・ダウコーニング・シリコーン株式会社 フッ素樹脂被覆定着ロール用シリコーンゴム組成物およびフッ素樹脂被覆定着ロール
JP3628809B2 (ja) * 1996-06-10 2005-03-16 アルケア株式会社 薬剤徐放性医療用配合物及びその製造方法
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
NZ536787A (en) 1998-06-11 2006-03-31 Endorech Inc Pharmaceutical compositions and uses for androst-5-ene-3beta,17beta diol
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
DE19905801B4 (de) * 1999-02-12 2008-03-13 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung folienförmiger Darreichungsformen
US6800329B2 (en) * 1999-02-12 2004-10-05 Lts Lohmann Therapie-Systeme Ag Method for producing film-type dosage
ES2194736T3 (es) 1999-07-02 2003-12-01 Lohmann Therapie Syst Lts Sistema de microdepositos sobre la base de polisiloxanos y disolvente ambifilos.
DE19958554C2 (de) * 1999-07-02 2002-06-13 Lohmann Therapie Syst Lts Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US6558695B2 (en) * 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
US6645520B2 (en) 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
US6602912B2 (en) 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6562368B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
US6565879B1 (en) 1999-12-16 2003-05-20 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
US6673363B2 (en) * 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6562369B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
US6582724B2 (en) 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
US6562370B2 (en) 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
WO2002011768A1 (en) 2000-08-03 2002-02-14 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
MXPA04007870A (es) * 2002-02-15 2005-06-20 Endorech Inc Derivados de bifenilo y su uso como agentes antiandrogenicos.
US7328706B2 (en) 2002-05-06 2008-02-12 Dynamic Mouth Devices Llc Therapeutic and protective dental device useful as an intra-oral delivery system
PL219512B1 (pl) * 2003-04-14 2015-05-29 Lohmann Therapie Syst Lts Plaster miejscowy, zastosowanie plastra miejscowego i sposób wytwarzania plastra miejscowego
AU2004283431B2 (en) 2003-10-10 2009-09-10 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
CN1930181A (zh) * 2004-01-07 2007-03-14 恩多研究公司 螺旋12定向的甾族药品
US20050181057A1 (en) * 2004-02-13 2005-08-18 Rosenberg Paul K. Vaginal lubricant
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US20060217691A1 (en) * 2005-02-25 2006-09-28 Georg Schuele Real-time therapeutic dosimetry based on dynamic response of treated tissue
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
US7709516B2 (en) 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
US20070048347A1 (en) * 2005-08-26 2007-03-01 Laura Bardach Intra-oral device for treating obesity
DK1937276T3 (da) 2005-10-12 2013-02-11 Besins Healthcare Luxembourg Forbedret testosterongel og fremgangsmåde til anvendelse deraf
NZ571460A (en) 2006-04-21 2010-10-29 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
US9284345B2 (en) 2007-04-12 2016-03-15 Endorecherche, Inc. 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
EP2381946A4 (en) * 2008-10-10 2012-08-08 Teva Womens Health Inc METHOD FOR THE TREATMENT OF VASOMOTOR SYMPTOMS IN CASE RATED PROSTATE RAY PATIENTS WITH LOW-DOSED CYPROTERONE ACETATE
EP4108216A1 (en) 2009-06-03 2022-12-28 Forsight Vision5, Inc. Anterior segment drug delivery
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
KR20150039882A (ko) 2010-06-16 2015-04-13 앙도르쉐르슈 인코포레이티드 에스트로겐-관련 질병의 치료 또는 예방 방법
RU2740680C2 (ru) 2011-09-14 2021-01-19 Форсайт Вижн5, Инк. Глазное вкладочное устройство и способы
US9750636B2 (en) 2012-10-26 2017-09-05 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
US9371264B2 (en) 2013-01-11 2016-06-21 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
US9682960B2 (en) 2013-12-19 2017-06-20 Endorecherche, Inc. Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US10575976B2 (en) 2015-04-30 2020-03-03 Dynamic Mouth Devices, L.L.C. Method and apparatus for weight management utilizing an intra-oral device
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
GB1412970A (en) * 1974-01-15 1975-11-05 Schering Ag Pharmaceutical preparations containing silicone rubber
AU7776275A (en) * 1974-04-11 1976-08-05 Warner Lambert Co Production of base for topical steroids
US4336243A (en) * 1980-08-11 1982-06-22 G. D. Searle & Co. Transdermal nitroglycerin pad

Also Published As

Publication number Publication date
GB2146526A (en) 1985-04-24
US5071657A (en) 1991-12-10
DK164482B (da) 1992-07-06
PT79182B (de) 1986-08-14
DE3333240A1 (de) 1985-03-28
GR80327B (en) 1985-01-02
PH21735A (en) 1988-02-10
ATE49126T1 (de) 1990-01-15
PT79182A (de) 1984-10-01
GB8422973D0 (en) 1984-10-17
NO843594L (no) 1985-03-13
DE3480905D1 (de) 1990-02-08
ZA847190B (en) 1985-04-24
EP0137278A2 (de) 1985-04-17
DK164482C (da) 1992-11-16
FI843580L (fi) 1985-03-13
FI843580A0 (fi) 1984-09-12
AU3284984A (en) 1985-03-21
EP0137278A3 (en) 1986-12-30
EP0137278B1 (de) 1990-01-03
FI83390C (fi) 1991-07-10
GB2146526B (en) 1987-12-09
CA1242143A (en) 1988-09-20
FI83390B (fi) 1991-03-28
DK433584D0 (da) 1984-09-11
ES8505248A1 (es) 1985-06-01
DK433584A (da) 1985-03-13
ES535860A0 (es) 1985-06-01

Similar Documents

Publication Publication Date Title
IL72897A0 (en) Preparation for the transdermal application of active substances,and processes for the preparation thereof
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
NO951592D0 (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
TW250435B (xx)
GB8804164D0 (en) Bandage for administering physiologically active compound
HU883863D0 (en) Process for the preparation of producing and/or portionly form of therapeutical agents
PL272134A1 (en) Plaster containing an active substance to be controlably introduced into skin tissue
PT879056E (pt) Modulacao da expressao das citocinas th1/th2 atraves de ribavirina em linfocitos t activados
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
AU3049489A (en) Crosslinked hydrophilic copolymer for medical and paramedical use
EP0295402A3 (en) Latex for immobilization of physiologically active substance and latex reagent using the latex
ZA878812B (en) 3-(omega(3,5-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles their deoxy analogs,and therapeutic uses thereof
JPS57139013A (en) Prophylactic or remedy for periodontosis
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
SE9101341D0 (sv) New medicinal use
ATE36333T1 (de) Hydantoin enthaltende therapeutische mittel.
PL332035A1 (en) Transdermal therapeutic system including an estriol-containing composition of active substances
EP0315300A3 (en) Treatment of tuberculous and nontuberculous mycobacterial infection
IT8407212A0 (it) Dispositivo di autocentratura, sostegno e valutazione dell'altezza del paziente per la radiografia dell'intero corpo umano (totalbody) con omografo.
HUT52391A (en) Composition(s), universally applicable medicinal cosmetic(s) absorbing through the skin (generally through the epithelium)
KR880005018U (ko) Crt모니터의 고무발 결착장치
IT1215117B (it) Procedimento per l'esecuzione di incavi all'interno di calibrature in cilindri di laminazione e dispositivo effettuante tale procedimento.